Tesamorelin 5mg × 10 vials

A synthetic growth hormone-releasing hormone analogue studied for growth hormone signaling, IGF-1 response, visceral fat research, metabolic regulation, and body composition support protocols.

Product Overview

Compound: Tesamorelin
Strength: 5 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Clinical reference dosing for approved tesamorelin medicines varies by formulation and is commonly listed as 1.4 mg, 1.28 mg, or 2 mg once daily by subcutaneous injection, depending on the vial formulation.

Notes

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone. It has been studied for stimulation of endogenous growth hormone secretion, IGF-1 response, visceral adipose tissue research, and metabolic protocols.

Tesamorelin should not be positioned as a general weight-loss product. No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.